House Health Care panel weighs S.28 telehealth abortion pathway, pharmacy label privacy

MONTPELIER, Vt. — The Vermont House Committee on Health Care on April 4 considered S.28, a bill “relating to access to certain legally protected health care services,” focusing on two linked issues: a provision that would permit patients to obtain medication abortion through an asynchronous telehealth visit using an adaptive questionnaire, and a separate provision directing how prescriber information appears on dispensed prescriptions for legally protected care.

Advocates and providers told the committee the asynchronous-adaptive approach could create a safer, confidential option for people experiencing reproductive coercion. Charlie Glesserman, policy director at the Vermont Network Against Domestic and Sexual Violence, told the committee that “asynchronous telehealth care through an adaptive questionnaire provides survivors with an option when a call or real time chat with a provider is not safe. This timely, confidential care can support survivors in accessing reproductive health care they need when they need it.”

The committee debated two technical but consequential drafting issues: language that would allow delegation of clinical tasks “by any combination of training, experience, education, or licensing credentials,” and the operational mechanics of removing or redacting prescriber-identifying information from labels and fulfilled-prescription materials.

Office of Legislative Counsel staff member Jen Carter summarized concerns raised by the Office of Professional Regulation (OPR) and licensing boards about delegation language. Carter said OPR worried that phraseology like “any combination” could be read to permit delegation to people acting outside the scope of an existing license, potentially exposing patients to unlicensed medical practice. To address questions about how an adaptive questionnaire would be governed, Carter proposed text that would deem a licensee who uses an adaptive questionnaire to have reviewed it and determined that it provides the information necessary “to meet the essential standards of acceptable and prevailing practice.”

Telehealth providers told the committee they already use standardized screening tools and best-practice processes. “We really are on top of it and trying to do this as perfectly as kind of done,” said Dr. Linda Fringe, who identified herself as a telehealth provider, supporting an exclusion that allows use of an adaptive questionnaire for prescribing medication without requiring an additional formal approval step at the questionnaire producer level.

Pharmacists and pharmacy representatives described operational constraints in removing provider names from printed labels. Jessa Bauder of the Vermont Clinic Society described a short-term operational workaround used by some pharmacies — blacking out or otherwise removing printed names before handing a fulfilled prescription to a patient — and urged a phased approach. Christina McLaughlin, representing the Vermont Pharmacists Association, cautioned that many pharmacy dispensing systems are national and cannot be edited to suppress a prescriber field before a label is generated. She said changing those systems would be costly and time consuming for independent retail pharmacies.

Committee members debated short- and longer-term fixes. Several legislators and stakeholders suggested allowing immediate redaction of printed labels as an interim measure while commissioning a larger, longer-term study or legislative effort to modify electronic prescribing and pharmacy-dispensing systems. One committee member noted that the confidentiality provision would also apply to some gender-affirming medications and is not limited to reproductive-health prescriptions.

No formal floor votes on S.28 were taken during the session. The committee agreed to continue work and to reconvene for markup and a possible vote the following Tuesday. Committee staff were asked to gather additional input from OPR, the Board of Medical Practice, pharmacy vendors and other licensing entities on (1) delegation language options that protect public safety while preserving lawful access, and (2) practicable, phased approaches for redaction or system changes that protect prescribers and patients.

Why it matters: The committee is balancing survivor safety and confidentiality against licensing and pharmacy operational concerns. If enacted, the adaptive-questionnaire pathway could expand asynchronous telehealth access to medication abortion and the confidentiality provisions could affect how pharmacies print labels and handle fulfilled prescriptions across Vermont — and prompt system changes by vendors if multiple states adopt similar protections.

What’s next: The committee scheduled continued markup and discussion for the next committee meeting; sponsors and stakeholders will submit proposed language revisions and operational proposals in advance of that session.